Search

everythinglearnresearchcommunity

for

Search:↓

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

TSH is usually the only test needed to check thyroid function in primary care.

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Thyroxine can adjust the body's peripheral clock, potentially helping treat clock-related diseases.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Women with excessive hair growth often have hormonal issues and need medical advice and treatment.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Thyroid problems are linked to various skin issues, and checking thyroid health is important for people with certain skin conditions.

Isotretinoin may cause temporary, reversible facial hair growth in some women.

PCOS diagnosis and management have improved with new guidelines for personalized care.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Dutasteride is more effective and better tolerated than finasteride for hair loss treatment.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

The document concludes that careful history and physical exams are crucial for accurately diagnosing polycystic ovary syndrome and distinguishing it from other similar conditions.

PCOS affects a similar percentage of Black and White women in the Southeastern United States.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

The document concludes that personalized hormonal treatments are important for transgender individuals and more research is needed for non-binary treatments.

Skin and hair changes in horses can indicate serious diseases, and recognizing these signs is important for treatment and management.

Adult acne is often related to hormonal disorders, especially in women, and may need long-term treatment involving specialists.

Genes and epigenetic changes are important in the development of Polycystic Ovary Syndrome.